Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Sleep Initiation and Maintenance Disorders 2Ovarian Neoplasms 1Lymphoma 1Leukemia, Myeloid, Acute 1Chronic Pain 1Anxiety Disorders 1

Interventions

Bevacizumab 35Paclitaxel 31Carboplatin 24pembrolizumab 23Specimen Handling 21Magnetic Resonance Spectroscopy 19Gemcitabine 18olaparib 16liposomal doxorubicin 16Cyclophosphamide 15fludarabine 12Topotecan 12Biopsy 12niraparib 11Cisplatin 10Taxes 8Nivolumab 8Immunoglobulin G 8Fulvestrant 8Disulfides 8Doxorubicin 7aldesleukin 6Surveys and Questionnaires 6palbociclib 5Oxaliplatin 5Fluorouracil 5trastuzumab deruxtecan 4oregovomab 4mirvetuximab soravtansine 4X-Rays 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ovarian Neoplasms × Cognitive Behavioral Therapy × 90 days × Clear all
NCT07550205 2026-04-24

Tiaoshen Anti-cancer Protocol and CBT for Insomnia and Survival in Ovarian Cancer

Shanghai Municipal Hospital of Traditional Chinese Medicine

Phase 2/3 Not yet recruiting
360 enrolled
Gynecologic

Sleep Initiation and Maintenance Disorders, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡